The Big View Podcast Por Reuters arte de portada

The Big View

The Big View

De: Reuters
Escúchala gratis

Obtén 3 meses por US$0.99 al mes

Reuters Breakingviews columnists tap their best contacts to explore the biggest issues driving business and markets today. Every Tuesday, Global Editor Peter Thal Larsen and his team tackle a pressing question with a senior executive, financier, policymaker, or other expert. The Big View helps you understand what is going on, explore all sides of the argument, and think about what happens next. [For previous The Exchange podcast users, we didn't want to leave you hanging so we've decided to repurpose this feed for the launch of The Big View podcast. You can still find the legacy episodes below marked under the old title]WW Política y Gobierno
Episodios
  • Judges under siege administer poetic justice
    Dec 9 2025
    As Congress cedes power to the White House, US courts are filling some of the void. In this episode of The Big View, Jeffrey Goldfarb talks to Reynolds Holding, the author of ‘Better Judgment’, about the sense of purpose among jurists ruling on corporate and human-rights matters. Visit the Thomson Reuters Privacy Statement for information on our privacy and data protection practices. You may also visit megaphone.fm/adchoices to opt-out of targeted advertising. Learn more about your ad choices. Visit megaphone.fm/adchoices
    Más Menos
    40 m
  • The past and future fight about who owns the land
    Nov 25 2025
    The world’s oldest asset is at the heart of political debate and underpins the modern financial system. In this episode of The Big View, Peter Thal Larsen talks to Mike Bird, author of “The Land Trap”, about why property is such an enduring issue – and why it’s so hard to reform. Visit the Thomson Reuters Privacy Statement for information on our privacy and data protection practices. You may also visit megaphone.fm/adchoices to opt-out of targeted advertising. Learn more about your ad choices. Visit megaphone.fm/adchoices
    Más Menos
    36 m
  • Pluses and minuses of the weight-loss drug bonanza
    Nov 18 2025
    Obesity treatments made by Novo Nordisk and Eli Lilly have spawned a healthcare revolution, with sales set to hit $150 bln by 2031. In this episode of The Big View, Peter Thal Larsen talks to Breakingviews Associate Editor Aimee Donnellan about their origins – and their impact. Visit the Thomson Reuters Privacy Statement for information on our privacy and data protection practices. You may also visit megaphone.fm/adchoices to opt-out of targeted advertising. Learn more about your ad choices. Visit megaphone.fm/adchoices
    Más Menos
    34 m
Todavía no hay opiniones